Stridon Clinical Research Limited

Chartered Accountants' report to the director on the preparation of the unaudited statutory accounts of Stridon Clinical Research Limited For The Year Ended 31 December 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Stridon Clinical Research Limited For The Year Ended 31 December 2024 which comprise the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given to us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at:-

http://www.icaew.com/en/membership/regulations-standards-and-guidance.

Our work has been undertaken in accordance with Technical release 07/16 AAF as detailed at icaew.com/compilation.

Signed

Powdin & Co

25 September 2025

Powdin & Co Limited

Chartered Accountants

Hampshire House, 204 Holly Road

Aldershot

Hampshire

GU12 4SE

Page 1

Stridon Clinical Research Limited

Balance Sheet

As At 31 December 2024

Balance Sheet

Registered number: 11177286

	2024	2023
	£	£
Fixed assets	13,538	14,038

Current assets	701,899	462,695
Prepayments and accrued income	803	775
Creditors: Amounts Falling Due Within One Year	(94,748 )	(66,871 )

NET CURRENT ASSETS	607,954	396,599

TOTAL ASSETS LESS CURRENT LIABILITIES	621,492	410,637

Accruals and deferred income	(395 )	(395 )

NET ASSETS	621,097	410,242

CAPITAL AND RESERVES	621,097	410,242

Notes

1. General Information

Stridon Clinical Research Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11177286 . The registered office is Hampshire House, 204 Holly Road, Aldershot, Hampshire, GU12 4SE.

2. Average Number of Employees

Average number of employees, including directors, during the year was: 1 (2023: 1)

For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors on 25 September 2025 and were signed on its behalf by:

Dr Radivoj Arezina

Director